Patents by Inventor Kanako NIIMORI

Kanako NIIMORI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicine for treating cancer and method for treating cancer
    Patent number: 11802284
    Abstract: An object of the present invention is to reveal a role of a stem cell control factor including Matrin-3 in cancer exhibiting neural differentiation including small cell lung cancer, and develop a medicine useful for treating cancer and the like based on the role. Among cancers having the cancer stem cell controlling mechanism, in cancer exhibiting the differentiation potency, the peculiar balance where both of expression of a stem cell maintenance factor and expression of a differentiation promoting factor are higher as compared with normal cells is retained. Additionally, in undifferentiated cancer, the peculiar balance where expression of a stem cell maintenance factor is higher as compared with normal cells is retained. In cancer in which the cancer stem cell controlling mechanism exists, these peculiar balances of a stem cell control factor different from the balance of normal cells exist.
    Type: Grant
    Filed: July 1, 2020
    Date of Patent: October 31, 2023
    Assignees: NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY, TOKYO INSTITUTE OF TECHNOLOGY
    Inventor: Kanako Niimori
  • MEDICINE FOR TREATING CANCER AND METHOD FOR TREATING CANCER
    Publication number: 20200339995
    Abstract: An object of the present invention is to reveal a role of a stem cell control factor including Matrin-3 in cancer exhibiting neural differentiation including small cell lung cancer, and develop a medicine useful for treating cancer and the like based on the role. Among cancers having the cancer stem cell controlling mechanism, in cancer exhibiting the differentiation potency, the peculiar balance where both of expression of a stem cell maintenance factor and expression of a differentiation promoting factor are higher as compared with normal cells is retained. Additionally, in undifferentiated cancer, the peculiar balance where expression of a stem cell maintenance factor is higher as compared with normal cells is retained. In cancer in which the cancer stem cell controlling mechanism exists, these peculiar balances of a stem cell control factor different from the balance of normal cells exist.
    Type: Application
    Filed: July 1, 2020
    Publication date: October 29, 2020
    Inventor: Kanako NIIMORI
  • MEDICINE FOR TREATING CANCER AND METHOD FOR TREATING CANCER
    Publication number: 20180179544
    Abstract: An object of the present invention is to reveal a role of a stem cell control factor including Matrin-3 in cancer exhibiting neural differentiation including small cell lung cancer, and develop a medicine useful for treating cancer and the like based on the role. Among cancers having the cancer stem cell controlling mechanism, in cancer exhibiting the differentiation potency, the peculiar balance where both of expression of a stem cell maintenance factor and expression of a differentiation promoting factor are higher as compared with normal cells is retained. Additionally, in undifferentiated cancer, the peculiar balance where expression of a stem cell maintenance factor is higher as compared with normal cells is retained. In cancer in which the cancer stem cell controlling mechanism exists, these peculiar balances of a stem cell control factor different from the balance of normal cells exist.
    Type: Application
    Filed: June 2, 2016
    Publication date: June 28, 2018
    Inventor: Kanako NIIMORI